Challenges of fragment screening

Journal of Computer-Aided Molecular Design

Volumn 23, Issue 8, 2009, Pages 449-451

  Joseph McCarthy, Diane ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA KINASE INHIBITOR; BETA SECRETASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; THROMBIN INHIBITOR;

BINDING SITE; COMBINATORIAL LIBRARY; COMPUTER AIDED DESIGN; DRUG SCREENING; EDITORIAL; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PHARMACOPHORE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; X RAY CRYSTALLOGRAPHY;

COMPUTER-AIDED DESIGN; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; SMALL MOLECULE LIBRARIES;

EID: 67650951119     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-009-9293-0     Document Type: Editorial

References (26)

1. Goodford P (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849-857
2. Miranker A, Karplus M (1991) Functionality maps of binding sites: A multiple copy simultaneous search method. Proteins 11:29-34
3. Evensen E, Joseph-McCarthy D, Karplus M (1997) MCSSv2. Harvard University, Cambridge
4. Evensen E et al (2007) Ligand design by a combinatorial approach based on modeling and experiment: Application to HLA-DR4. J Comput Aided Mol Des 21:395-418
5. Gillet VJ et al (1995) SPROUT, HIPPO and CAESA: Tools for de novo structure generation and estimation of synthetic accessibility. Perspect Drug Discov Des 3:34-50
6. Carlson HA et al (2000) Developing a dynamic pharmacophore model for HIV-1 integrase. J Med Chem 43(11):2100-2114
7. Bohm HJ (1992) Ludi - rule-based automatic design of new substituents for enzyme-inhibitor leads. J Comput Aided Mol Des 6(6):593-606
8. Bohm HJ (1994) On the use of Ludi to search the fine chemicals directory for ligands of proteins of known 3-dimensional structure. J Comput Aided Mol Des 8(5):623-632
9. Verdonk ML, Cole JC, Taylor R (1999) SuperStar: A knowledge-based approach for identifying interaction sites in proteins. J Mol Biol 289(4):1093-1108
10. Joseph-McCarthy D, Alvarez JC (2003) Automated generation of MCSS-derived pharmacophoric DOCK site points for searching multiconformation databases. Proteins 51:189-202
11. Joseph-McCarthy D et al (2003) Pharmacophore-based molecular docking to account for ligand flexibility. Proteins 51:172-188
12. Lauri G, Bartlett PA (1994) Caveat - a program to facilitate the design of organic-molecules. J Comput Aided Mol Des 8(1):51-66
13. Eisen MB et al (1994) HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding sites. Proteins 19:199-221
14. Maass P et al (2007) Recore: A fast and versatile method for scaffold hopping based on small molecule crystal structure conformations. J Chem Inf Model 47:390-399
15. Thompson DC et al (2008) Confirm: Connecting fragments in receptor molecules. J Comput Aided Mol Des 22:761-772
16. Moriaud F et al. (2009) Computational Fragment-Based Approach at PDB Scale by Protein Local Similarity. J Chem Inf Model ahead of print
17. Chen Y, Shoichet BK (2009) Molecular docking and ligand specificity in fragment-based inhibitor discovery. Nat Chem Biol 5:358-364
18. Hajduk PJ, Huth JR, Fesik SW (2005) Druggability indices for protein targets derived from NMR-based screening data. J Med Chem 48:2518-2525
19. Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Disc 4:649-663
20. Howard N et al (2006) Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors. J Med Chem 49:1346-1355
21. Hartshorn MJ et al (2005) Fragment-based lead discovery using X-ray crystallography. J Med Chem 48:403-413
22. Howard S et al (2009) Fragment-based discovery of the Pyrazol-4-yl Urea (AT9283), a multi targeted kinase inhibitor with potent aurora kinase activity. J Med Chem 52(2):379-388
23. Card GL et al (2005) A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design. Nat Biotechnol 23:201-207
24. Edwards PD et al (2007) Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency. J Med Chem 50(24):5912-5925
25. Geschwindner S et al (2007) Discovery of a novel warhead against beta-secretase through fragment-based lead generation. J Med Chem 50(24):5903-5911
26. Albert JS et al (2007) An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes. Curr Top Med Chem 7(16):1600-1629